AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06736236 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle warm-up
Description: This study will use a respiratory muscle warm-up protocol set at 40% of the maximal inspiratory pressure (MIP) using the POWERbreath® device, as this intensity has been shown to optimally stimulate respiratory muscles. The protocol involves two sets of 30 breaths with a 60-second rest between sets, performed with participants sitting and using a nose clip. Participants will be trained in this technique during the familiarization session and monitored throughout the tests to ensure proper execution.
Study NCT06736236 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: General warm-up (Control)
Description: The general warm-up (Control) protocol will include exercises such as running and dynamic, active, and passive movements tailored to the diverse sports disciplines in the study. These movements will follow the principles of elevation, activation, and mobilization, focusing on increasing mobility from the arms and shoulders to the lower back and legs. Each session will involve demonstrations emphasizing proper technique and speed, with participants completing a consistent number of repetitions. Researchers will monitor participants closely to ensure correct form and execution throughout the intervention.
Study NCT06736236 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Inspiratory muscle warm-up placebo (IMW %15)
Description: The respiratory muscle warm-up protocol will be conducted at 15% of maximal inspiratory pressure (MIP) using the POWERbreath® device. This placebo protocol will involve two sets of 30 breaths, separated by a 60-second rest, with participants seated and wearing a nose clip. Training for the technique will occur during a familiarization session, and participants will be observed during tests to ensure proper execution. The purpose of this protocol is to serve as a placebo, masking the actual aim of the study to enhance data reliability.
Study NCT06748469 — intervention group
Intervention type: PROCEDURE
Intervention: The duration of the intervention will be 240 seconds
Description: Dorsal Root Ganglion pulsed radiofrequency 240sec
Study NCT06748469 — intervention group
Intervention type: PROCEDURE
Intervention: Dorsal Root Ganglion pulsed radiofrequency 480sec
Description: The duration of the intervention will be 480 seconds
Study NCT06748430 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Grape variety control
Description: Reference grape variety
Study NCT06748430 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Grape variety 1
Description: First grape variety to evaluate
Study NCT06748430 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Grape variety 2
Description: Second grape variety to evaluate
Study NCT06748573 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SafeGuard FocusTM compression bandage
Description: If randomized to the study group, The study device was applied immediately after pocket closure using following steps:~* Preparation: cleaning wound and surrounding area.~* Placement: application of isobetadine gauze and transparent bandage. Study device placement at the level of the pocket.~* Applying compression: inflation of 60ml of air. If oozing persisted 5ml increments were added (maximum of 120ml) until oozing stopped.~The study device was gradually deflated by removal of 20ml of air every 2 hours. When oozing occurred 5ml increments were added until oozing stopped. When all air was deflated the study device was left in deflated mode and changed by conventional bandage at discharge.
Study NCT06748573 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional bandage
Description: If randomized to the control group, compressive bandage was applied immediately after pocket closure. The bandage was removed after 6 hours and changed by conventional bandage.
Study NCT06749275 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 5,000 ppm fluoride toothpaste
Description: In group 1, toothbrushing with toothpaste of 5,000 ppm of fluoride twice per day for two minutes, after breakfast and before bedtime. Participants will be also instructed not to rinse with water after brushing and to only eliminate the excess of the dentifrice by spitting out. The amount of toothpaste to be used had to be about the size of a pea.
Study NCT06749275 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 22,600 ppm fluoride varnish
Description: The application protocol of 5% fluoride varnish will be used together with the 1,450 ppm paste with the same protocol of the group 1: toothbrushing with toothpaste of 1.450 ppm of fluoride twice per day for two minutes, after breakfast and before bedtime. Participants will be also instructed not to rinse with water after brushing and to only eliminate the excess of the dentifrice by spitting out. The amount of toothpaste to be used had to be about the size of a pea.
Study NCT06297317 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Ultrasound measurement of triceps surae muscle-tendon architecture
Description: The resting plantar-flexors MTU architecture assessment was performed using a conventional B-mode and extended-field-of-view (EFOV) ultrasound imaging. Achille tendon cross-sectionnal area, Medial gastrocnemius thickness, pennation angle, fascicle length and muscle length were collected on the dominant lower limb.
Study NCT06749275 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 38% SDF
Description: The application protocol of 38% SDF annually will be used together with the 1,450 ppm paste with the same protocol of the group 2: toothbrushing with toothpaste of 1.450 ppm of fluoride twice per day for two minutes, after breakfast and before bedtime. Participants will be also instructed not to rinse with water after brushing and to only eliminate the excess of the dentifrice by spitting out. The amount of toothpaste to be used had to be about the size of a pea.
Study NCT06750211 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: METs
Description: * Hot pack for 10 minutes.~* Neck isometrics with 10 second hold.~* Each series of neck isometrics strengthening exercises had three movements including cervical flexion, cervical extension and cervical side flexion.~* Muscle energy technique protocol: The individual was in a position of supine. The therapist was at the edge of bed, near the participants head. the therapist positioned the joint at the point of beginning range of motion resistance when performing a given movement. When the therapist felt restriction, positioned the cervical spine in that region and apply the resistive force. Patient was instructed to contract isometrically for five seconds without exceeding the therapist force. thereafter, therapist counterforce gradually reduced and patient was asked to relaxed. Therapist move the joint into new point of barrier and same protocol repeated three times.~Patient came thrice per week for a total of 4 weeks.
Study NCT06750211 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MCTE along with METs
Description: ▪ Hot pack for 10 minutes.~* Neck isometrics with 10 second hold.~* Each series of neck isometrics strengthening exercises had three movements including cervical flexion, cervical extension and cervical side flexion.~* After it was treated with motor control therapeutic exercises together with muscle energy technique. Motor control therapeutic exercises included cranio-cervical flexor exercises, cranio-cervical extensor exercises, co contraction of flexor and extensor and synergy exercise for strengthening deep neck flexor. Exercises were performed in three sets with 10 repetitions with an approximate duration of 10 to 20 minutes. They were advised to perform at home once in a day, five times in a week for a duration of 4 weeks.~All exercises were performed three times per week for total of 4 weeks.
Study NCT06750354 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: papworth technique
Description: For Group A: The Papworth breathing technique consists of a series of diaphragmatic breathing and relaxation exercises, and teaches patients which muscles to use when breathing and how to avoid breathing too or too fast by emphasizing nose breathing. The technique is altered to suit activity; this allows the technique to be integrated by patients into their everyday lives with subsequent improvements in quality of life.
Study NCT06750354 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: aerobic training
Description: Aerobic training exercises are any activities that raise heart rate and make breathing somewhat harder. The activity you are doing must be constant and continuous. Examples of aerobic activities are~Walking or hiking Jogging or running Biking Swimming Rowing In-line skating Cross-country skiing Exercising on a stair-climber or elliptical machine
Study NCT06750354 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: aerobic training
Description: Aerobic training exercises are any activities that raise heart rate and make breathing somewhat harder. The activity you are doing must be constant and continuous. Examples of aerobic activities are~Walking or hiking Jogging or running Biking Swimming Rowing In-line skating Cross-country skiing Exercising on a stair-climber or elliptical machine
Study NCT06308315 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rhythmic balance visual auditory exercise + Routine physical therapy
Description: 5 minute warm-up activities.~Bal-A-Vis-X training includes:~1. Ball Rectangle; A and B hold one ball in each hand, simultaneously bounce right balls to patient left hand; while balls bounce, clap left balls on right hand; catch patient ball with left hand; continue pattern. Bounces must be simultaneous. (10 minutes)~2. Ball rectangle in which one hand has to toss a ball to a partner and the other hand catch an incoming bag from the partner and 2 ball drop/pass/catch, two-foot jumping forward, tandem walking on ground. (10 minutes)~Routine Physical therapy treatment includes:~Range of Motion exercises, Stretching, Strength, balance training for 15 minutes~5 minute cool-down activities.
Study NCT06308315 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Strength Training + Routine Physical Therapy
Description: The expert managed sessions based on:~5 minute warm-up activities. 5 minute cool-down activities. Strength training includes 5 tasks for 20 minutes~1. core strengthening,~2. upper and lower limbs strength in both static positions as well as with dynamic movements~3. standing long jump,~4. knee push-ups,~5. sit-ups~Routine Physical therapy treatment will be given for 15 minutes.~It includes:~Range of Motion exercises, Stretching, Strength, balance training.
Study NCT04860466 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CC-96673
Description: IV Infusion
Study NCT06266689 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Personalized Diet Information
Description: These participants will receive a report detailing their genomic food data based on the investigators' DNA metabarcoding technique in addition to standard dietary guidance to see if receiving the report modifies what they choose to feed their infant.
Study NCT06049212 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Sacituzumab tirumotecan
Description: Sacituzumab tirumotecan injection powder for intravenous (IV) infusion.
Study NCT06049212 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Pembrolizumab solution for IV infusion.
Study NCT06043882 — intervention group
Intervention type: PROCEDURE
Intervention: flexible bronchoscopy
Description: fiberoptic bronchoscopy was done where biopsies were taken either by conventional TBNA (c-TBNA) , EBUS-TBNA or direct forceps biopsies and sent for histopathological examination
Study NCT04857957 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral dose CNTX-6016 or oral dose Placebo
Description: CNTX-6016 or Placebo
Study NCT04989192 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Scan at CT scanner 1
Description: Patients will undergo imaging on a modern CT scanner with spectral imaging capabilities. A dose neutral spectral acquisition mode will routinely be used. Contrast material protocol and scan ranges are similar among all three arms.
Study NCT04605276 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study NCT04987775 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: N-Acetyl Cysteine
Description: 900mg 2x daily
Study NCT04987775 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo bid
Study NCT05463419 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PIKA COVID-19 vaccine
Description: SARS-CoV-2 spike subunit protein (Also called Recombinant SARS-CoV-2 S-trimer protein), PIKA adjuvant.
Study NCT05463419 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Inactivated Covid-19 vaccine
Description: Inactivated SARS-CoV-2 virus
Study NCT06116123 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Massage mattress with cube/block system
Description: Patients with an odd number were assigned to group I, while those with an even number were allocated to group II. Patients in group I were provided with a pressure sore prevention bed featuring a support surface with vibration (massage) capabilities, a cube/block system creating a low-pressure area, and a ventilation system, routinely utilized in the unit. For group II patients, a viscoelastic pressure sore prevention mattress with an orthopedic support surface, routinely employed in the unit, was used.Within the first six hours after admission, patients in both groups underwent initial assessments using the Braden Scale to determine their pressure sore risk. Both groups were monitored for a maximum of four weeks, with daily pressure ulcer assessments conducted using the Pressure Ulcer Observation Form. Pressure sore area in both groups was calculated in square centimeters (cm2) using the Wound Measurement Ruler.
Study NCT06298058 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SIBP-A13 formulation for injection
Description: SIBP-A13: injection; strength: 1, 2, 4, 5, 6 or 8 mg; dose escalation and the first group is 1mg (intravenous infusion). Starting from the lowest dose, when the former does not meet the termination criteria, then start the next dose group study until Maximum Tolerated Dose (MTD). The study adopts a 3+3 dose increasing design. Administration period: divided into single administration and multiple administration. Single dose administration: The participants are administered a single dose on the first day for a total of 21 days of observation, and complete the examinations and evaluations specify in the protocol. If dose-limiting toxicity (DLT) does not occur, the participant enters a multiple dosing period. Multiple administration: administration every 3 weeks.
Study NCT06497140 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ethiodized Oil-based emulsion
Description: Embolization of genicular arteries
Study NCT06497140 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham-operation
Description: Mimicked catheterization and embolization of genicular arteries
Study NCT06472856 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Acupuncture
Description: Acupuncture will be given using single use sterile stainless steel 34 gauge (Japanese size: 0.20 X 30 mm) filoform needles. Skin will be swabbed with an alcohol prep pad before acupuncture is administered. Needles will be inserted 0.5 to 1.0 centimetres deep into the skin and gently manipulated to create the deqi sensation. No electrical stimulation will be used.
Study NCT06327165 — intervention group
Intervention type: OTHER
Intervention: observation
Description: The ANI monitor calculates heart rate variability mediated by changes in the parasympathetic nervous system.
Study NCT04989192 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Scan at CT scanner 2
Description: Patients will undergo imaging on a modern 128 slice CT-scanner without spectral imaging capabilities. A standard acquisition protocol will be used. Contrast material protocol and scan ranges are similar among all three arms.
Study NCT04989192 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Scan at CT scanner 3
Description: Patients will undergo imaging on a modern 20 slice CT-scanner without spectral imaging capabilities. A standard acquisition protocol will be used. Contrast material protocol and scan ranges are similar among all three arms.
Study NCT06571539 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AR-assisted EVD placement
Description: Cfr. arm description
Study NCT06571539 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Freehand EVD placement
Description: External ventricular drain (EVD) placement using the conventional freehand technique. This intervention covers the matched, non-concurrent control group, retrospectively obtained without active enrollment to receive study treatment.
Study NCT06570421 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Peroneal electrical transcutaneous neuromodulation (peroneal eTNM®)
Description: This is a non-invasive intervention, which utilizes direct transcutaneous, electrical stimulation of the peroneal nerve
Study NCT06168773 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Haloperidol Injection
Description: to evaluate the efficacy and safety of short-term intravenous combination of low-dose haloperidol and magnesium for delirium prevention in critically ill elderly patients after elective major surgery.
Study NCT06168773 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Haloperidol Injection
Description: to evaluate the efficacy and safety of short-term intravenous combination of low-dose haloperidol and magnesium for delirium prevention in critically ill elderly patients after elective major surgery.
Study NCT05380700 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual Reality Stimulation
Description: Participants in the intervention group will be provided with up to 30 minutes of relaxing, 360-degree virtual reality (VR) stimulation and corresponding sounds, twice in 24 hours during their stay on the intermediate care unit.
Study NCT01134692 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propranolol, Norfloxacin, VSL#3
Description: Propranolol: as per heart rate titration Norfloxacin: 400mg BD
Study NCT01134692 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Propranolol, Norfloxacin, VSL#3
Description: Propranolol: as per heart rate titration Norfloxacin: 400mg BD
Study NCT01134692 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propranolol, Norfloxacin, VSL#3
Description: Propranolol: as per heart rate titration Norfloxacin: 400mg BD
Study NCT05704231 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral: Motivational Interviewing with WhatsApp video call
Description: The intervention group will be given a motivational interview with a WhatsApp video call for 3 months. Motivational interviews will be applied every two weeks, 6 times in total.
Study NCT03537794 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: PET scans
Description: PET scans and PHNO scans
Study NCT06500507 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: QLS4131 Injection
Description: Participants confirming to the eligibility criteria will be assigned to 1 of the 9 dose groups (0.06/0.3/1 \~ 600 ug/kg, respectively) based on the sequence of inclusion.
Study NCT06564714 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Early baclofen Intervention
Description: Baclofen is initiated as soon as any sign of acute spasticity.~5 mg three times a day and is increased every 7 days by 5 mg per intake (up to a maximum 80 mg total per day) until achieving an optimal response, i.e. when spasticity is no longer problematic.
Study NCT06564714 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Usual routine care
Description: Baclofen is initiated only when acute spasticity is deemed problematic.~5 mg three times a day and is increased every 7 days by 5 mg per intake (up to a maximum 80 mg total per day) until achieving an optimal response.
Study NCT06563648 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: shotblocker
Description: A ShotBlocker was placed on the arm of the patients in the ShotBlocker group during the injection, and the injection was performed from the part where the opening was located by lightly pressing with the fingertips throughout the injection.
Study NCT06563648 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: local cold application
Description: Local cold application was applied to the arm of the patients in the local cold application group for five minutes using a cold pack, and then the injection was performed.
Study NCT06563648 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ShotBlocker placebo group
Description: During the injection, the back side of the ShotBlocker was placed on the arm of the patients in the ShotBlocker placebo group and the injection was performed by gently pressing with the fingertips throughout the injection.
Study NCT05755958 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: HIFU treatment in rectal Endometriosis
Description: HIFU treatment of rectal endometriosis
Study NCT05755958 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: SHAM HIFU procedure
Description: SHAM HIFU procedure
Study NCT03925194 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anakinra
Description: Application of Anakinra once daily for 28 days
Study NCT03925194 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Anakinra
Description: Application of Anakinra once daily for 28 days
Study NCT06367101 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: AR training with gait and HRV feedback
Description: Use projection-based AR system to train gait and HRV. To give gait and HRV feedback for subjects after AR training.